Characteristics | Discovery set | Replication set |
---|---|---|
 | (n = 48) | (n = 97) |
Age group | ||
 < 50 years | 26(54.2%) | 22(45.8%) |
 ≥ 50 years | 48(49.5%) | 49(50.5%) |
Stage | ||
 Stage I | 11(22.9%) | 25(25.8%) |
 Stage II | 37(77.1%) | 72(74.2%) |
 Stage IIA | 26 | 50 |
 Stage IIB | 11 | 22 |
ER status | ||
 Positive | 25(52.1%) | 54(55.7%) |
 Negative | 23(47.9%) | 43(44.3%) |
PR status | Â | Â |
 Positive | 35(72.9%) | 59(60.8%) |
 Negative | 13(27.1%) | 38(39.2%) |
HER2 status | ||
 Positive | 11(22.9%) | 23(23.7%) |
 Negative | 37(77.1%) | 74(76.3%) |
Subtype | Â | Â |
 Luminal A | 29(60.4%) | 53(54.6%) |
 Luminal B | 10(20.8%) | 16(16.5%) |
 HER2 | 1(2.1%) | 7(7.2%) |
 TNBC | 8(16.7%) | 21(21.6%) |